Clinical Trial Update: Safety of 4CMenB Exposure During Pregnancy

View source ↗

Summary

Clinical trial update reporting safety data on exposure to 4CMenB during pregnancy; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections

Drugs mentioned

• 4CMenB (bivalent group B meningococcal vaccine (4CMenB))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Status: COMPLETED | Results posted: 2020-09-03